Article

Essilor, Transitions offer customers a little TLC

Essilor of America (EOA) now offers a combination of Crizal anti-reflective coatings and Transitions photochromic lenses for Total Light Control (TLC).

Dallas-Essilor of America (EOA) now offers a combination of Crizal anti-reflective coatings and Transitions photochromic lenses for Total Light Control (TLC).

According to the company, TLC "successfully controls light, providing patients with optimal vision."

"Light is central to good vision," said Carl Bracy, vice president of marketing for Essilor. "By communicating the benefits of Crizal and Transitions lenses together, we are able to offer our eye-care professionals and their patients the best overall lens performance, quality of vision, and the preservation and protection of the health and well-being of their eyes."

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Barsha Lal, PhD, discusses the way low dose atropine affects accommodative amplitude and dynamics at the 2025 ARVO meeting
(Image credit: Ophthalmology Times) NeuroOp Guru: When eye findings should prompt neuroimaging in suspected neuro-Behcet disease
At the Association for Research in Vision and Ophthalmology (ARVO) meeting, Katherine Talcott, MD, a retina specialist at Cleveland Clinic, shared her findings on EYP-1901 (EyePoint Pharmaceuticals) in the phase 2 DAVIO study.
Dr. Jogin Desai, founder of Eyestem Research, discusses his research at the Association for Research in Vision and Ophthalmology.
(Image credit: Ophthalmology Times) ASCRS 2025: Michael Rivers, MD, shares his takeaways as a panelist at the inaugural SightLine event
(Image credit: Ophthalmology Times) ASCRS 2025: Karl Stonecipher, MD, on LASIK outcomes using an aspheric excimer laser for high myopia
John Tan talks about an emergency triage framework for retinal artery occlusion at the 2025 Association for Research in Vision and Ophthalmology (ARVO) meeting.
Dr Robert Maloney at the 2025 Controversies in Modern Eye Care meeting
Wendy Lee, MD, MS, at Controversies in Modern Eye Care 2025.
© 2025 MJH Life Sciences

All rights reserved.